logo-loader
viewMediclinic International Plc

Mediclinic downgraded to 'neutral' by JP Morgan Cazenove

There were some positive signs in yesterday's trading update in that the Abu Dhabi business appears to be recovering, but ...

Patient healthcare
The main concern for the private healthcare provider is Switzerland

There are signs of light in the desert but clouds are gathering in the mountains, said JP Morgan Cazenove, waxing lyrical about Mediclinic International Plc (LON:MDC).

The clouds in the (Swiss) mountains are evidently blocking out the sun in the (UAE) desert, because Cazenove downgraded the private healthcare provider to “neutral” from “overweight”.

The price target has been slashed from 898p to 733p.

The broker said Mediclinic’s half-year (H1) statement was “again disappointing”.

The United Arab Emirates (UAE) business might be recovering but the Swiss and Southern African operations appear to be under greater pressure.

Cazenove expects the current financial year to be tough and next year will probably be tough as well, and there are few near-term share price catalysts.

“Nonetheless the assets are well invested and in our view there is fat in the business, creating options. We continue to see longer-term value and believe MDC is oversold but uncertainties remain and investor patience will likely be required,” the broker suggested.

Quick facts: Mediclinic International Plc

Price: 394.5 GBX

LSE:MDC
Market: LSE
Market Cap: £2.91 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

ROBO Global team discuss its focus on innovation and key developments in AI

ROBO Global's director of research Jeremie Capron and strategic adviser Wyatt Newman discuss the firm's focus on technology innovation and the importance of taking a longer-term view when it comes to its investments. They also discuss what they consider to be some of the key upcoming...

1 hour, 29 minutes ago

2 min read